Tilray Brands (TLRY) Stock Overview
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
TLRY Community Fair Values
Create NarrativeSee what 174 others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Tilray Brands, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.46 |
| 52 Week High | US$23.20 |
| 52 Week Low | US$3.51 |
| Beta | 2.12 |
| 1 Month Change | -23.25% |
| 3 Month Change | -39.84% |
| 1 Year Change | -24.65% |
| 3 Year Change | -76.61% |
| 5 Year Change | n/a |
| Change since IPO | -95.37% |
Recent News & Updates
Tilray: Rescheduling Rally Meets Equity Erosion & Short Interest Volatility
Jan 28Lacklustre Performance Is Driving Tilray Brands, Inc.'s (NASDAQ:TLRY) 30% Price Drop
Jan 16
Recent updates
Tilray: Rescheduling Rally Meets Equity Erosion & Short Interest Volatility
Jan 28Lacklustre Performance Is Driving Tilray Brands, Inc.'s (NASDAQ:TLRY) 30% Price Drop
Jan 16Tilray Brands, Inc. (NASDAQ:TLRY) Looks Inexpensive After Falling 39% But Perhaps Not Attractive Enough
Nov 24Tilray Brands, Inc.'s (NASDAQ:TLRY) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
Oct 03Tilray Brands, Inc. (NASDAQ:TLRY) Surges 66% Yet Its Low P/S Is No Reason For Excitement
Aug 18Tilray Brands, Inc. (NASDAQ:TLRY) Shares Fly 35% But Investors Aren't Buying For Growth
Jul 04
Integrated Operations Will Extend European And US THC Beverage Markets
Strategic initiatives focusing on margin improvements and global expansion efforts could significantly boost profitability and revenue growth.Tilray Brands Could Bounce Big
Apr 28Tilray: Q3 Earnings Could Be The Inflection Point It Needs
Apr 09Lacklustre Performance Is Driving Tilray Brands, Inc.'s (NASDAQ:TLRY) 28% Price Drop
Mar 26Tilray Short Interest Surges Again
Mar 13Tilray: Improved Balance Sheet And Reasonable Valuation (Rating Upgrade)
Feb 17Investors Don't See Light At End Of Tilray Brands, Inc.'s (NASDAQ:TLRY) Tunnel And Push Stock Down 27%
Feb 07Tilray: Back To Square One (Rating Downgrade)
Jan 14Tilray: FQ2 Results Unlikely To Impress Below The Top Line
Jan 08US Delta-9 THC Markets And German Medical Cannabis Synergize Tilray's Potential
Dec 27Tilray Brands May Bounce
Dec 15Here's Why Shareholders May Want To Be Cautious With Increasing Tilray Brands, Inc.'s (NASDAQ:TLRY) CEO Pay Packet
Dec 13Shareholder Returns
| TLRY | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -14.5% | -0.03% | -0.2% |
| 1Y | -24.6% | 24.8% | 13.5% |
Return vs Industry: TLRY underperformed the US Pharmaceuticals industry which returned 24.8% over the past year.
Return vs Market: TLRY underperformed the US Market which returned 13.5% over the past year.
Price Volatility
| TLRY volatility | |
|---|---|
| TLRY Average Weekly Movement | 19.3% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TLRY's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: TLRY's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,842 | Irwin Simon | www.tilray.com |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products.
Tilray Brands, Inc. Fundamentals Summary
| TLRY fundamental statistics | |
|---|---|
| Market cap | US$869.14m |
| Earnings (TTM) | -US$2.11b |
| Revenue (TTM) | US$837.32m |
Is TLRY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TLRY income statement (TTM) | |
|---|---|
| Revenue | US$837.32m |
| Cost of Revenue | US$602.65m |
| Gross Profit | US$234.67m |
| Other Expenses | US$2.34b |
| Earnings | -US$2.11b |
Last Reported Earnings
Nov 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -18.09 |
| Gross Margin | 28.03% |
| Net Profit Margin | -251.69% |
| Debt/Equity Ratio | 16.2% |
How did TLRY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/02 12:44 |
| End of Day Share Price | 2026/01/30 00:00 |
| Earnings | 2025/11/30 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tilray Brands, Inc. is covered by 27 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Jesse Pytlak | ATB Cormark Historical (Cormark Securities) |